B. Metzler seel. Sohn & Co. AG Has $1.10 Million Position in Innospec Inc. $IOSP

Key Points

• B. Metzler seel. Sohn & Co. AG reduced its holdings in Innospec Inc. by 53.8% during the first quarter, now owning approximately 11,559 shares valued at about $1.1 million.
• Other investors, including Vanguard Group and Victory Capital Management, have increased their stakes in Innospec, indicating strong institutional interest with 96.64% of the company's stock owned by institutional investors.
• Innospec reported quarterly earnings of $1.26 per share, exceeding analyst expectations, despite a slight decline in revenue compared to the previous year.

B. Metzler seel. Sohn & Co. AG decreased its stake in Innospec Inc. (NASDAQ:IOSP - Free Report) by 53.8% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,559 shares of the specialty chemicals company's stock after selling 13,472 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Innospec were worth $1,095,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Tsfg LLC acquired a new stake in Innospec during the 1st quarter worth about $35,000. Caitong International Asset Management Co. Ltd acquired a new stake in Innospec during the 1st quarter worth about $121,000. State of Wyoming boosted its position in Innospec by 167.0% during the 4th quarter. State of Wyoming now owns 1,976 shares of the specialty chemicals company's stock worth $217,000 after acquiring an additional 1,236 shares during the period. Quantinno Capital Management LP acquired a new stake in Innospec during the 4th quarter worth about $237,000. Finally, R Squared Ltd acquired a new stake in Innospec during the 1st quarter worth about $262,000. Institutional investors and hedge funds own 96.64% of the company's stock.

Innospec Stock Performance

Shares of Innospec stock traded down $0.64 during trading on Thursday, hitting $85.17. 51,928 shares of the stock traded hands, compared to its average volume of 200,377. The stock has a market cap of $2.11 billion, a P/E ratio of 109.19 and a beta of 1.11. Innospec Inc. has a twelve month low of $74.10 and a twelve month high of $128.35. The company has a fifty day moving average price of $84.65 and a two-hundred day moving average price of $89.23.

Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The firm had revenue of $439.70 million during the quarter, compared to analyst estimates of $440.70 million. During the same quarter in the previous year, the business earned $1.39 EPS. The business's revenue was up 1.1% on a year-over-year basis. On average, equities research analysts expect that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.